Neogap Therapeutics

NEOGAP Therapeutics is a privately held biopharmaceutical company primarily focused on immuno-oncology. Founded by Dr. Hans Grönlund in 2016, the company is located at the Center for Molecular Medicine at the Karolinska Institute in Stockholm, Sweden. The vision of Neogap Therapeutics is to improve overall survival rates for cancer patients by enhancing tumor-specific responses of the immune system. The mission of Neogap Therapeutics is to become a key player in the fight against cancer through the development and commercialization of our innovative cancer immunotherapies.